Subscribe to Newsletter

Manufacture

Manufacture Contract Manufacturing Services

Key Considerations When Partnering with a CDMO for Your Plasma-Derived Therapies

| Jeff Morier, James O’Meara | 5 min read

Experts from Emergent BioSolutions break down the qualities that make an ideal CDMO partner for plasma- based protein manufacturing

Manufacture Advanced Medicine

Viable Viruses

| Neil Ward | 4 min read

Could non-pathogenic viruses provide an unrejectable therapeutic target?

Manufacture Facilities

Taking Sustainability to Heart: An Interview With ten23 Health

| Stephanie Vine | 11 min read

We sit down with Hanns-Christian Mahler, CEO of ten23 health.

Manufacture Bioprocessing - Upstream & Downstream

Less Patience, More Patients

| 4 min read

Sitting Down With Dick Sundh, General Manager, Kite Pharma

Manufacture Facilities

Center of Excellence Opens for RNA

| Stephanie Vine | 4 min read

UK-based center will have capacity for RNA therapeutic production for clinical trials and potential future health emergencies.

Manufacture Advanced Medicine

Cell yourself

| Molly Mjolsness | 5 min read

Navigating the cell therapy partnership selection process can be complex. Here, I share the questions you should be asking to help you get it right.

Manufacture Technology and Equipment

Tooling Up for Biopharma’s Digital Future

| Sponsored by Sartorius | 7 min read

How digitalization will revolutionize the way we develop and optimize bioprocesses.

Manufacture Bioprocessing - Upstream & Downstream

Getting More from Your Buffer Management Strategy

| Sponsored by Asahi Kasei Bioprocess | 7 min read

We delve into the story behind Lonza’s collaboration with Asahi Kasei Bioprocess America.

Manufacture Bioprocessing - Upstream & Downstream

Planes, Trains, and Autologous Therapies

| Sumukhi Sreevatsan | 3 min read

The potential of the cell and gene therapies sector depends – partially – on the expertise of the transport and logistics partners that complement it.

Manufacture Bioprocessing - Upstream & Downstream

The Viral Frontier

| Natalia Elizalde | 3 min read

How can companies beat the bottlenecks in viral vector manufacturing?

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register